Abstract:Key PointsInnate lymphoid cells (ILCs) are newly identified members of the lymphoid lineage with emerging roles in mediating immune responses and in regulating tissue homeostasis and inflammation.The existence of different ILC populations that can rapidly secrete immunoregulatory cytokines suggests that these cells may have evolved to provide immunity to infections. Indeed, it is notable that ILC subsets seem to be particularly prevalent at mucosal surfaces, which are constantly exposed to infectious agents in the external environment.The group 1 ILC lineage comprises ILCs such as natural killer (NK) cells that produce type 1 cytokines, notably interferon-γ and tumour necrosis factor. Other group 1 ILCs have been reported, mainly in vitro, and their physiological roles remain to be defined.The group 2 ILC population comprises ILC2s, which express interleukin-5 (IL-5) and IL-13 and require GATA-binding protein 3 (GATA3) and retinoic acid receptor-related orphan receptor-α (RORα) for their development. They have crucial roles in protective type 2 immunity to helminth infection. Furthermore, although T helper 2 cells are a major source of type 2 cytokines during allergic asthma, ILC2s also contribute to disease pathology.ILC3s were first defined as intestinal lymphoid cells that express the NK cell activating receptor NKp46, but otherwise bear little functional resemblance to conventional NK cells, and require RORγ for their development. They express IL-17A and IL-22.Recent studies have also implicated ILC3s in the development of inflammatory bowel disease. Studies in Rag2−/− mice demonstrated that, in the early phase of Citrobacter rodentium infection, IL-22 is produced from an innate cell source.Lymphoid tissue-inducer (LTi) cells are an ILC subset that appears to be closely related to ILC3s, but their exact relationship remains controversial. Together, LTi cells and ILC3s have been classified as group 3 ILCs.

A Murine Intestinal Intraepithelial NKp46-Negative Innate Lymphoid Cell Population Characterized by Group 1 Properties

Tissue-specific transcriptional profiles and heterogeneity of natural killer cells and group 1 innate lymphoid cells

Innate lymphoid cells — how did we miss them?

An in vitro model of innate lymphoid cell function and differentiation

Identification of porcine ileal innate lymphoid cells using single-cell RNA sequencing

Group 1 ILCs: Heterogeneity, plasticity, and transcriptional regulation

CD8αα TCRαβ Intraepithelial Lymphocytes in the Mouse Gut

Maximum immunobioactivity of murine small intestinal intraepithelial lymphocytes resides in a subpopulation of CD43+ T cells

Natural killer cells and type 1 innate lymphoid cells in cancer

Dependence of innate lymphoid cell 1 development on NKp46.

Advances in innate lymphoid cells

Subsets of ILC3−ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues

Single-cell RNA-sequencing identifies the developmental trajectory of C-Myc-dependent NK1.1− T-bet+ intraepithelial lymphocyte precursors

Type 1 Innate Lymphoid Cells Limit the Antitumoral Immune Response

Origin, trafficking, and intraepithelial fate of gut-tropic T cells

Differential Phenotypic and Functional Properties of Liver-Resident NK Cells and Mucosal ILC1s.

Expansion and Function of Cd8(+) T Cells, Expressing Ly49 Inhibitory Receptors Specific for Mhc Class I Molecules

CD56 Expression Marks Human Group 2 Innate Lymphoid Cell Divergence from a Shared NK Cell and Group 3 Innate Lymphoid Cell Developmental Pathway

Identification of Group 2 Innate Lymphoid Cells in Mouse Lung, Liver, Small Intestine, Bone Marrow, and Mediastinal and Mesenteric Lymph Nodes

T-Bet Controls Cellularity of Intestinal Group 3 Innate Lymphoid Cells

Innate Lymphoid Cells and Inflammatory Bowel Disease